For Immediate Release
Chicago, IL – May 31, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Tesla, Inc. (
TSLA Quick Quote TSLA - Free Report) , TotalEnergies SE ( TTE Quick Quote TTE - Free Report) , Intuitive Surgical, Inc. ( ISRG Quick Quote ISRG - Free Report) , The Charles Schwab Corp. ( SCHW Quick Quote SCHW - Free Report) and Monster Beverage Corp. ( MNST Quick Quote MNST - Free Report) . Here are highlights from Tuesday’s Analyst Blog: Top Research Reports for Tesla, TotalEnergies and Intuitive Surgical
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Tesla, TotalEnergies SE and Intuitive Surgical, Inc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>> Tesla’s shares have outperformed the Zacks Automotive - Domestic industry over the year-to-date period (+56.9% vs. +33.8%). The electric vehicle (EV) giant witnessed record deliveries for Models 3 and Y. The Zacks analyst expects deliveries to see an annualized growth of around 37% in 2023. Production ramp-up at gigafactory 4 (in Berlin) and 5 (in Austin) and introduction of new models, including Semi and Cybertruck, are set to support long-term deliveries growth. We anticipate automotive revenues to rise 19% this year. Additionally, Tesla’s energy generation and storage revenues outlook is promising. Falling debt levels is another positive. While inflation and economic concerns could pose near-term challenges, we expect Tesla to deliver outsized returns in the long run on the back of output ramp-up and introduction of new models. (You can ) read the full research report on Tesla here >>> Shares of TotalEnergies have outperformed the Zacks Oil and Gas - Refining and Marketing industry over the past year (+6.8% vs. -6.8%). The company continues to benefit from startups, well-spread LNG assets and an expanding upstream portfolio that has exposure to fast-growing hydrocarbon-producing regions. Lower exposure to mature assets compared with the other oil and gas majors acts as a tailwind. TTE streamlines its portfolio through acquisitions, partnerships and divestitures. TTE is making steady investments to expand the renewable operation and aims to achieve net-zero emissions by 2050. Yet, TTE’s production is impacted by the security-related production cuts in some regions. TTE remains exposed to acquisition-related risks as these assets contribute a sizable volume to production. A natural decline in production and TTE’s withdrawal from Russia might affect profitability. (You can ) read the full research report on TotalEnergies here >>> Shares of Intuitive Surgical have outperformed the Zacks Medical - Instruments industry over the past year (+34.8% vs. -2.0%). The da Vinci procedure volume continued its recovering trend of 2022 into the first quarter of 2023, which is likely to persist for the rest of the year. Improving procedure volume along with better system placements and services across all markets will drive top-line growth in 2023. Intuitive Surgical witnessed healthy customer demand for its products in the quarter under review. Its Ion platform has strong growth potential. A stable liquidity position is an added plus. However, higher component and labor costs, and a strong U.S. dollar continues to hurt gross margin. Stiff competition in the global MedTech space and rising costs remain concerns for Intuitive Surgical. (You can ) read the full research report on Intuitive Surgical here >>> Other noteworthy reports we are featuring today include The Charles Schwab and Monster Beverage Corp.
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss
. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.